Stating that it was “disappointed and concerned” by the action of the European Union imposing a ban on the sale of around 700 pharma products clinically tested by GVK Biosciences, Hyderabad, the Narendra Modi government on Wednesday said it has decided to defer the talks on the India-EU free trade agreement (FTA), officially called the broad-based bilateral trade and investment agreement...While the issue is restricted to the alleged flaws in GVK Biosciences’ studies, government sources in New Delhi apprehend that it could potentially lead to a clampdown on India’s pharmaceutical exports to the continent.